The trajectory of Viagra, formerly marketed by copyright, presents a intricate case study for stakeholders considering the healthcare sector. While its early success and generation of billions in revenue , the exclusivity expiration has opened the floodgates for generic medications, greatly eroding earnings prospects . This shift raises questions a